Anosmia and hyposmia, the inability or decreased ability to smell, is estimated to afflict 3–
20% of the population. Risk of olfactory dysfunction increases with old age and may also …

Background The literature regarding clinical olfaction, olfactory loss, and olfactory
dysfunction has expanded rapidly over the past two decades, with an exponential rise in the …

Objectives To evaluate the role of the topical corticosteroid, mometasone furoate, nasal
spray in the treatment of post COVID-19 anosmia. Methods A prospective, randomized …

During the initial pandemic wave of COVID-19, apart from common presenting symptoms
(cough, fever, and fatigue), many countries have reported a sudden increase in the number …

The sense of smell essentially contributes to social communication, guides nutrition
behaviour and elicits avoidance towards environmental hazards. Olfactory smell impairment …

The loss of the senses of smell (anosmia) and taste (ageusia) are rather common disorders,
affecting up to 20% of the adult population. Yet, this condition has not received the attention …

Humans have deliberately scented their environment for purpose or pleasure for millennia.
In the contemporary marketplace most consumers prefer and purchase scented versions of …

Background The burden of long-term symptoms (ie, long COVID) in patients after mild
COVID-19 is debated. Within a cohort of healthcare workers (HCWs), frequency and risk …

Background The burden of long-term symptoms (ie long-COVID) in patients after mild
COVID-19 is debated. Within a cohort of healthcare workers (HCW), frequency and risk …

Background Olfactory dysfunction (OD) is common in the general population, affects the
quality of life (QoL), and is suspected to cause depression. Long-term outcome data are …